The impact of intrauterine devices on subsequent fertility

Current Opinion in Obstetrics and Gynecology

Volumn 20, Issue 3, 2008, Pages 275-280

  Skjeldestad, Finn E ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Fertility; Infertility; Intrauterine contraceptive devices; Pregnancy outcome

Indexed keywords

BIRTH RATE; CLINICAL FEATURE; DEVICE REMOVAL; ECTOPIC PREGNANCY; ENDOMETRITIS; FAMILY PLANNING; FEMALE FERTILITY; FEMALE INFERTILITY; FOLLOW UP; GESTATIONAL AGE; HUMAN; INDUCED ABORTION; INTRAUTERINE CONTRACEPTIVE DEVICE; NULLIPARA; PATHOPHYSIOLOGY; PELVIC INFLAMMATORY DISEASE; PREGNANCY OUTCOME; PREGNANCY RATE; PREGNANCY TERMINATION; PRIORITY JOURNAL; REVIEW; SALPINGITIS; SURVIVAL RATE; SYMPTOM; UTERINE TUBE MUCOSA;

FEMALE; FOLLOW-UP STUDIES; HUMANS; INFERTILITY, FEMALE; INTRAUTERINE DEVICES; PELVIC INFLAMMATORY DISEASE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 43149121763     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/GCO.0b013e3282fe7427     Document Type: Review

References (41)

1. French R, Van Vliet H, Cowan F, et al. Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. Cochrane Database Syst Rev 2004; (3):CD001776. doi: 10.1002/14651858.CD001776.pub2.
2. World Health Organization. Medical eligibility criteria for contraceptive use. 3rd ed. Geneva: World Health Organization; 2004.
3. World Health Organization. Selected practice recommendations for contraceptive use. 2nd ed. Geneva: World Health Organization; 2004.
4. UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction. A plethora of IUDs: but how safe, how effective? Prog Reprod Health Res 2002; 60:3.
5. Burkman RT. Association between intrauterine device and PID. Obstet Gynecol 1981; 57:269-276.
6. Lee NC, Rubin GL, Ory HW, Burkman RT. Type of intrauterine device and the risk of pelvic inflammatory disease. Obstet Gynecol 1983; 62:1-6.
7. Lee NC, Rubin GL, Borucki R. The intrauterine device and pelvic inflammatory disease revisited: new results from the Women's Health Study. Obstet Gynecol 1988; 72:1-6.
8. Kronmal RA, Whitney CW, Mumford SD. The intrauterine device and pelvic inflammatory disease: the Women's health study reanalyzed. J Clin Epidemiol 1991; 44:109-122.
9. Daling JR, Weiss NS, Metch BJ. Primary tubal infertility in relation to the use of an intrauterine device. N Engl J Med 1985; 312:937-941.
10. Cramer DW, Schiff I, Schoenbaum SC. Tubal infertility and the intrauterine device. N Engl J Med 1985; 312:941-947.
11. Daling JR, Weiss NS, Voigt LF, et al. The intrauterine device and primary tubal infertility. N Engl J Med 1992; 326:203-204.
12. Mueller BA, Luz-Jimenez M, Daling JR, et al. Risk factors for tubal infertility. Sex Transm Dis 1992; 19:28-34.
13. Hubacher D, Lara-Ricalde R, Taylor DJ, et al. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med 2001; 345:561-567.
14. Luukkainen T, Allonen H, Nielsen N-C, et al. Five years' experience of intrauterine contraception with the Nova-T and the Copper-T-200. Am J Obstet Gynecol 1983; 147:885-892.
15. Bratt H, Skjeldestad FE, Valentin KC. A randomized trial of three copper IUDs. Acta Obstet Gynecol Scand 1988; 67:147-151.
16. WHO: special programme of research, development and research training in human reproduction. The TCu380A, TCu220C, Multiload 250 and Nova-T IUDs at 3, 5 and 7 years of use - results from three randomized multicentre trials. Contraception 1990; 42:141-158.
17. Fylling P. Clinical performance of Copper-T-200, Multiload-250 and Nova-T: a comparative multicentre study. Contraception 1987; 35:439-446.
18. Sivin I, Diaz J, Alvarez F, et al. Four-year experience in a randomized study of the GYNE-T* 380 Slimline and the standard GYNE-T 380 intrauterine copper devices. Contraception 1993; 47:37-42.
19. Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova-T) IUDs during five years of use: a randomized comparative study. Contraception 1994; 49:56-72.
20. Kets Van HE, Pas Van Der H, Delbarge W, Thiery M. A randomized comparative study of the TCU380A and Cu-Safe 300 IUDs. Adv Contracept 1995; 11:123-129.
21. Haugan T, Skjeldestad FE, Halvorsen LE, Kahn H. Bottom of form a randomized trial on the clinical performance of Nova T380 and Gyne T380 Slimline copper IUDs. Contraception 2007; 75:171-176. Provides reassuring results on low incidence of PID in a large 5-year randomized clinical trial on IUD performance.
22. Pyörälä T, Allonen H, Nygren KG, et al. Return of fertility after the removal of Nova-T or Copper-T-200. Contraception 1982; 26:113-120.
23. Skjeldestad FE, Bratt H. Fertility after complicated and noncomplicated use of IUDs. A controlled prospective study. Adv Contracept 1988; 4:179-184.
24. Garmo Hov G, Skjeldestad FE, Hilstad T. Use of IUD and subsequent fertility - follow-up after participation in a randomized clinical trial. Contraception 2007; 75:88-92. Provides high-quality results on return of fertility rates, need for infertility work-up and pregnancy outcome in a complete cohort of women recruited from a randomized clinical trial.
25. Westrøm L. Effect of acute pelvic inflammatory disease on fertility. Am J Obstet Gynecol 1975; 121:707-713.
26. Skjeldestad FE, Bratt H. Return of fertility after use of IUDs (Nova-T, MLCu250 and MLCu375). Adv Contracept 1987; 3:139-145.
27. Belhadj H, Sivin I, Diaz S, Pavez M. Recovery of fertility after use of the levonogestrel 20mcg/d or copper T 380 Ag intrauterine device. Contraception 1986; 34:261-267.
28. Rioux J-E, Cloutier D, Dupont P, Lamonde D. Pregnancy after IUD use. Adv Contracept 1986; 2:185-192.
29. Sivin I, Stern J, Diaz S, et al. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices. Am J Obstet Gynecol 1992; 166:1208-1213.
30. Andersson K, Batar I, Rybo G. Return to fertility after removal of levonorgestrel-releasing intrauterine device and Nova-T. Contraception 1992; 46:575-584.
31. Randic L, Vlasic S, Matrljan I, Waszak CS. Return to fertility after IUD removal for planned pregnancy. Contraception 1985; 32:253-259.
32. Sandmire HF. Fertility after intrauterine device discontinuation. Adv Contracept 1986; 2:327-335.
33. Wilson JC. A prospective New Zealand study of fertility after removal of copper intrauterine contraceptive devices for conception and because of complications: a four year study. Am J Obstet Gynecol 1989; 160:391-396.
34. Doll H, Vessey M, Painter R. Return of fertility in nulliparous women after discontinuation of the intrauterine device: comparison with women discontinuing other methods of contraception. Br J Obstet Gynecol 2000; 108:304-314.
35. Bakken IJ, Skjeldestad FE. Time trends in ectopic pregnancy in a Norwegian county 1970-2004 - a population-based study. Hum Reprod 2006; 21:3132-3136.
36. Nybo Andersen AM, Wohlfahrt J, Christens P, et al. Maternal age and fetal loss: a population based register linkage study. BMJ 2000; 320:1708-1712.
37. Vessey MP, Lawless M, McPhersson K, Yeates D. Fertility after stopping use of intrauterine contraceptive device. Br Med J 1983; 286:106.
38. Farley TMM, Rowe PJ, Meirik O, et al. IUDs and pelvic inflammatory disease. Lancet 1992; 340:248-249.
39. Skjeldestad FE, Halvorsen LE, Kahn H, et al. IUD users in Norway are at low risk for genital C. trachomatis infection. Contraception 1996; 54:209-212.
40. Grimes DA. Intrauterine devices and upper genital-tract infection. Lancet 2000; 356:1013-1019.
41. Darney PD. Time to pardon the IUD? N Engl J Med 2001; 345:608-610.